Showing 1011-1020 of 1395 results for "".
The Role of Presbyopia-Correcting Drops
https://modernod.com/cme/ophthalmology/The-Role-of-Presbyopia-Correcting-Drops-2508/29737/Learn about miotics and how they work for presbyopia correction, especially for certain patients who are not ready for surgical options.Achieving Durable Outcomes in Treatment-Naïve nAMD
https://modernod.com/specialty/retina/Achieving-Durable-Outcomes-in-treatment-naive-nAMD-2506/33189/Drs. Garg and Wykoff discuss a treatment-naïve patient with neovascular age-related macular degeneration and the impact of second-generation agents.Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
https://modernod.com/cme/ophthalmology/Sustaining-Vision-Empowering-Optometry-for-Tomorrows-Retinal-Care/32392/Join Drs. Khanani, Sheth, and Vajzovic, to learn how to educate patients about alternative treatment options for retinal diseases.- New Collaboration to Produce Opticianry-Focused Educational Panel at OptiCon ’26https://modernod.com/news/new-collaboration-to-produce-opticianry-focused-educational-panel-at-opticon-26/2485385/The Contact Lens Institute (CLI) and the United Opticians Association (UOA) announced a new collaboration to co-produce "Vision for Growth: Consumer Perspectives on Opticianry & Contact Lens Success," an educational panel exclusive to OptiCon ’26 @ Vision Expo.
- US States Sue 26 Generic Drugmakers for Alleged Price Fixinghttps://modernod.com/news/us-states-sue-26-generic-drugmakers-for-alleged-price-fixing/2479522/A coalition of 51 US states and territories filed a lawsuit in federal court in Connecticut on Wednesday, accusing 26 drug companies, including Taro, Perrigo, Novartis’ Sandoz unit, Actavis, Mylan, Teva, G&W and Glenmark, of conspiring to fix prices and allocate markets for at least 80
- CooperVision MiSight 1 Day Officially Launches in Chinahttps://modernod.com/news/coopervision-misight-1-day-officially-launches-in-china/2481026/CooperVision and EssilorLuxottica have officially launched MiSight 1 day contact lenses in China, marking its availability in the world’s largest country for myopia management. It is the first product of any type that has an indication from the Chinese National Medical Products Adminis
- Allergan Announces Official Launch of the TrueTear Intranasal Neurostimulation Devicehttps://modernod.com/news/allergan-announces-launch-of-the-truetear-intranasal-neurostimulation-device-at-ascrs/2480250/Allergan announced the official launch of TrueTear, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients. TrueTear, a handheld neurostimulation device with disposable tips that is inserted into the nasal cavity to
- Euclid Vision Announces Official Launch of Cloud-Based Portalhttps://modernod.com/news/euclid-vision-announces-official-launch-of-cloud-based-portal/2480964/Euclid Vision has announced the official rollout of MyEuclid, an interactive, web-based customer portal designed to drive practice efficiency and optimize Euclid Ortho-K fits. The MyEuclid portal was released on a limited basis earlier this year, and the platform is now availa
- Eyenuk Secures $26 Million Series A Funding to Accelerate Global Access to AI-Powered Eye-Screening Technologyhttps://modernod.com/news/eyenuk-secures-26-million-series-a-funding-to-accelerate-global-access-to-ai-powered-eye-screening-technology/2481183/Eyenuk announced it has secured $26 million in a Series A financing round, bringing the company’s total funding to over $43 million. The capital raise was led by AXA IM Alts and was joined by new and existing investors including T&W Medical A/S, A&C Foelsgaard Alternativer ApS,
- Strategic National Stockpile Aims to Get 400M Syringes by December for COVID-19 Vaccine: Officialshttps://modernod.com/news/strategic-national-stockpile-aims-to-get-400m-syringes-by-december-for-covid-19-vaccine-officials/2477888/Trump administration officials want to stockpile 400 million syringes and needles by December in anticipation of a COVID-19 vaccine, according to a FierceHealthcare report. Administration officials testified before Congress on Tuesday on the procurement of supplies during the COVID-19 pand